Coty Sales Fall 7% in Q3 as Company Records Significant Impairment Charge

Coty's third-quarter financial results revealed a 7% decline in sales, driven by structural pressures in the Consumer Beauty segment which incurred a $363 million impairment charge. Despite these headwinds, the company reaffirmed its full-year EBITDA guidance of $838 million to $848 million. According to reports, leverage has risen to 3.4x, while risks surrounding the 2028 expiry of the Gucci license continue to weigh on long-term sentiment.

This performance aligns with a broader slowdown in global beauty demand, as market data shows similar margin compression among peers like Estée Lauder, which recently lowered its annual outlook (per Reuters). Compared to previous quarters, Coty is grappling with rising debt servicing costs and deteriorating fundamentals in mass-market products, contrasting with the relative resilience seen in the ultra-prestige fragrance category.

Investors are monitoring COTY shares, which stood at $10.45 (at close May 14, 2026), as they look for technical support levels. Forward-looking catalysts include the impact of recent consumer data, such as the Michigan Consumer Sentiment index which came in at 48.2 (below the 49.5 forecast), potentially signaling weaker discretionary spending. The primary focus remains on management's ability to deleverage ahead of upcoming debt maturities.